Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07680842 · ClinicalTrials.gov registry record · NA

Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy

A NA study, sponsored by University of California, San Francisco.

Recruiting
Registry status
NA
Development phase
40
Enrollment target

NCT07680842 is a NA study that is actively recruiting participants, run by University of California, San Francisco. The registered enrollment target is 40 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07680842, a NA study, is actively recruiting participants, sponsored by University of California, San Francisco.

RECRUITING
Registry status
NA
Development phase
40 participants
Enrollment target

Study Summary

The goal of this study is to investigate the effects of a non-invasive, low intensity focused ultrasound (LIFU) stimulation on seizure frequency and the epileptogenic network in drug-resistant epilepsy. LIFU uses focused sound waves to modulate deep brain regions and to enable changes in brain network activity. Encephalography (EEG) and behavioral tasks will also be used to study how LIFU affects brain activity.

Interventions

  • DEVICE Target optimization using LIFU
  • DEVICE Serial LIFU stimulation

Trial Details

FieldValue
Enrollment Target 40 participants
Start Date 2025-07-09
Est. Completion 2027-06-01
Phase NA

What the Registry Record Tells You About NCT07680842

The ClinicalTrials.gov registry entry for NCT07680842 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 40 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which Target optimization using LIFU is the first listed.

NCT07680842 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT07680842 about?

NCT07680842 is a clinical study titled "Non-Invasive Low Intensity Focused Ultrasound Stimulation for Drug-Resistant Epilepsy". The goal of this study is to investigate the effects of a non-invasive, low intensity focused ultrasound (LIFU) stimulation on seizure frequency and the epileptogenic network in drug-resistant epilepsy. LIFU uses focused sound waves to modulate deep brain regions and to enable changes in brain netwo...

What is the current status of trial NCT07680842?

This trial is currently recruiting. It is a NA study. The enrollment target is 40 participants. The study started on 2025-07-09. Estimated completion is 2027-06-01.

What interventions are being tested in trial NCT07680842?

The interventions under investigation include: Target optimization using LIFU (DEVICE), Serial LIFU stimulation (DEVICE).

Who is sponsoring clinical trial NCT07680842?

This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.